Summary of Discontinued Operations |
The following tables summarizes the assets and liabilities of the discontinued operations as of June 30, 2020 and December 31, 2019:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
June 30, 2020 |
|
December 31, |
|
|
(unaudited) |
|
2019 |
Assets |
|
|
|
|
Current assets: |
|
|
|
|
Accounts receivable, net |
|
$ |
— |
|
|
$ |
497,577 |
|
Total current assets of discontinued operations |
|
$ |
— |
|
|
$ |
497,577 |
|
|
|
|
|
|
Liabilities |
|
|
|
|
Current liabilities: |
|
|
|
|
Accounts payable |
|
$ |
— |
|
|
$ |
387,975 |
|
Accrued expenses and other current liabilities |
|
5,549,751 |
|
|
3,503,037 |
|
Total current liabilities of discontinued operations |
|
5,549,751 |
|
|
3,891,012 |
|
Other long-term liabilities |
|
— |
|
|
1,755,000 |
|
Total long-term liabilities of discontinued operations |
|
$ |
— |
|
|
$ |
1,755,000 |
|
The following table summarizes the results of discontinued operations for the three and six months ended June 30, 2020 and 2019:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
|
|
Six Months Ended June 30, |
|
|
|
|
2020 |
|
2019 |
|
2020 |
|
2019 |
Product revenue, net |
|
$ |
(455,463) |
|
|
$ |
3,057,462 |
|
|
$ |
(1,172,805) |
|
|
$ |
5,892,537 |
|
|
|
|
|
|
|
|
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
Cost of product sales |
|
— |
|
|
1,354,855 |
|
|
— |
|
|
2,550,199 |
|
General and administrative |
|
— |
|
|
41,374 |
|
|
— |
|
|
82,747 |
|
Sales and marketing |
|
— |
|
|
2,610,990 |
|
|
— |
|
|
5,323,616 |
|
Amortization expense |
|
— |
|
|
744,099 |
|
|
— |
|
|
1,488,199 |
|
Impairment of intangible assets |
|
— |
|
|
1,449,121 |
|
|
— |
|
|
1,449,121 |
|
Change in fair value of contingent consideration |
|
— |
|
|
284,800 |
|
|
— |
|
|
444,261 |
|
Total operating expenses |
|
— |
|
|
6,485,239 |
|
|
— |
|
|
11,338,143 |
|
Other (expense) income: |
|
|
|
|
|
|
|
|
Change in value of Guarantee |
|
— |
|
|
— |
|
|
1,755,000 |
|
|
— |
|
Interest expense, net |
|
— |
|
|
(238,158) |
|
|
— |
|
|
(476,316) |
|
Total other (expense) income |
|
— |
|
|
(238,158) |
|
|
1,755,000 |
|
|
(476,316) |
|
(Loss) income from discontinued operations before tax |
|
(455,463) |
|
|
(3,665,935) |
|
|
582,195 |
|
|
(5,921,922) |
|
Income tax expense |
|
— |
|
|
12,971 |
|
|
— |
|
|
48,658 |
|
(Loss) income from discontinued operations, net of tax |
|
$ |
(455,463) |
|
|
$ |
(3,678,906) |
|
|
$ |
582,195 |
|
|
$ |
(5,970,580) |
|
|
|
|
|
|
|
|
|
|
The significant non-cash operating items from the discontinued operations for the six months ended June 30, 2020 and 2019 are contained below. There were no non-cash investing items from the discontinued operations for the six months ended June 30, 2020 and 2019.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended June 30, |
|
|
|
|
2020 |
|
2019 |
Operating activities |
|
|
|
|
Amortization |
|
$ |
— |
|
|
$ |
1,488,199 |
|
Impairment of intangible assets |
|
— |
|
|
1,449,121 |
|
Stock-based compensation, excluding amount included within gain on sale of Pediatric Portfolio |
|
— |
|
|
202,330 |
|
Change in fair value of contingent consideration liability |
|
— |
|
|
444,261 |
|
Change in value of Guarantee |
|
(1,755,000) |
|
|
— |
|
|